TY - JOUR
T1 - The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
AU - Gladman, Dafna
AU - Ginzler, Ellen
AU - Goldsmith, Charles
AU - Fortin, Paul
AU - Liang, Matthew
AU - Urowitz, Murray
AU - Bacon, Paul
AU - Bombardieri, Stefano
AU - Hanly, John
AU - Hay, Elaine
AU - Isenberg, David
AU - Jones, John
AU - Kalunian, Kenneth
AU - Maddison, Peter
AU - Nived, Ola
AU - Petri, Michelle
AU - Richter, Martin
AU - Sanchez-Guerrero, Jorge
AU - Snaith, Michael
AU - Sturfelt, Gunnar
AU - Symmons, Deborah
AU - Zoma, Asad
PY - 1996/3
Y1 - 1996/3
N2 - Objective. To develop and perform an initial validation of a damage index for systemic lupus erythematosus (SLE). Methods. A list of items considered to reflect damage in SLE was generated through a nominal group process. A consensus as to which items to be included in an index was reached, together with rules for ascertainment. Each center submitted 2 assessments, 5 years apart, on 2 patients with active and 2 with inactive disease, of whom 1 had increased damage and the other had stable disease. Analysis of variance was used to test the factors physician, time, amount of damage, and activity status. Results. Nineteen physicians completed the damage index on 42 case scenarios. The analysis revealed that the damage index could identify changes in damage seen in patients with both active and inactive disease. Patients who had active disease at both time points had a higher increase in damage. There was good agreement among the physicians on the assessment of damage in these patients. Conclusion. This damage index for SLE records damage occurring in patients with SLE regardless of its cause. The index was demonstrated to have content, face, criterion, and discriminant validity.
AB - Objective. To develop and perform an initial validation of a damage index for systemic lupus erythematosus (SLE). Methods. A list of items considered to reflect damage in SLE was generated through a nominal group process. A consensus as to which items to be included in an index was reached, together with rules for ascertainment. Each center submitted 2 assessments, 5 years apart, on 2 patients with active and 2 with inactive disease, of whom 1 had increased damage and the other had stable disease. Analysis of variance was used to test the factors physician, time, amount of damage, and activity status. Results. Nineteen physicians completed the damage index on 42 case scenarios. The analysis revealed that the damage index could identify changes in damage seen in patients with both active and inactive disease. Patients who had active disease at both time points had a higher increase in damage. There was good agreement among the physicians on the assessment of damage in these patients. Conclusion. This damage index for SLE records damage occurring in patients with SLE regardless of its cause. The index was demonstrated to have content, face, criterion, and discriminant validity.
UR - http://www.scopus.com/inward/record.url?scp=13344270914&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=13344270914&partnerID=8YFLogxK
U2 - 10.1002/art.1780390303
DO - 10.1002/art.1780390303
M3 - Article
C2 - 8607884
AN - SCOPUS:13344270914
SN - 2326-5191
VL - 39
SP - 363
EP - 369
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 3
ER -